Texas Attorney General Sues Acetaminophen Makers Concerning Autism Spectrum Claims

Courtroom Proceedings
Ken Paxton, a Trump ally seeking election to the United States Senate, claimed the drug companies of hiding the risks of acetaminophen

Texas Attorney General Paxton is taking legal action against the manufacturers of Tylenol, claiming the corporations hid safety concerns that the drug presented to children's neurological development.

The lawsuit follows four weeks after Donald Trump publicized an unverified association between taking acetaminophen - referred to as acetaminophen - while pregnant and autism spectrum disorder in young ones.

Paxton is filing suit against J&J, which formerly manufactured the medication, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he stated they "deceived the public by profiting off of pain and marketing drugs ignoring the risks."

The company asserts there is lacking scientific proof connecting Tylenol to autism.

"These manufacturers lied for decades, deliberately risking countless individuals to increase profits," the attorney general, a Republican, said.

The manufacturer commented that it was "deeply concerned by the spread of false claims on the security of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its online platform, Kenvue also mentioned it had "regularly reviewed the relevant science and there is no credible data that demonstrates a established connection between consuming paracetamol and autism."

Groups representing doctors and health professionals share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the key substance in acetaminophen - is among limited choices for pregnant women to treat pain and fever, which can present significant medical dangers if ignored.

"In multiple decades of research on the utilization of paracetamol in gestation, no reliable research has conclusively proven that the consumption of paracetamol in any period of gestation leads to neurodevelopmental disorders in offspring," the association commented.

The lawsuit references recent announcements from the Trump administration in arguing the drug is reportedly hazardous.

In recent weeks, the former president generated worry from health experts when he told expectant mothers to "struggle intensely" not to use Tylenol when sick.

The US Food and Drug Administration then published an announcement that doctors should consider limiting the use of Tylenol, while also mentioning that "a direct connection" between the drug and autism in young ones has remains unverified.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had pledged in April to undertake "a massive testing and research effort" that would establish the source of autism spectrum disorder in a short period.

But experts cautioned that identifying a unique factor of autism - considered by experts to be the result of a intricate combination of genetic and environmental factors - would prove challenging.

Autism is a type of enduring cognitive variation and condition that influences how individuals encounter and interact with the surroundings, and is diagnosed using physician assessments.

In his legal document, Paxton - aligned with the former president who is running for federal office - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the research" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "remove any commercial messaging" that claims acetaminophen is secure for women during pregnancy.

The Texas lawsuit parallels the complaints of a group of parents of young ones with autism and ADHD who sued the makers of Tylenol in two years ago.

The court threw out the lawsuit, saying investigations from the plaintiffs' authorities was inconclusive.

Thomas Reyes
Thomas Reyes

A seasoned journalist with a passion for investigative reporting and storytelling, focusing on media ethics and digital culture.

June 2025 Blog Roll